Antimalarial drug resistance, in particular resistance to Plasmodium falciparum, challenges
the treatment and control of malaria. In this Review, we summarise evolving patterns of …

Abstract Purpose of Review Five years have passed since the World Health Organization
released its Global Technical Strategy for Malaria (GTS). In that time, progress against …

Background Trials of intermittent preventive treatment (IPTp) of malaria in pregnant women
that compared dihydroartemisinin-piperaquine with the standard of care, sulfadoxine …

The global spread of sulfadoxine (Sdx, S) and pyrimethamine (Pyr, P) resistance is attributed
to increasing number of mutations in DHPS and DHFR enzymes encoded by malaria …

Background Usage of chloroquine was discontinued from the treatment of Plasmodium
falciparum infection in almost all endemic regions because of global spread of resistant …

Background Malaria is a major public health issue with substantial risks among vulnerable
populations. Currently, the World Health Organization (WHO) recommends SP-IPTp in the …

Introduction Malaria is still a public health problem in Africa. Seasonal Malaria
Chemoprevention (SMC) is an efficient control strategy recommended by WHO that targets …

Background Intermittent preventive treatment with monthly dihydroartemisinin-piperaquine
(DHA-PQ) is highly effective at preventing both malaria during pregnancy and placental …

Abstract The World Health Organization (WHO) recommends surveillance of molecular
markers of resistance to anti-malarial drugs. This is particularly important in the case of mass …

Intermittent preventive treatment (IPT) with dihydroartemisinin-piperaquine (DP) is highly
protective against malaria in children, but is not standard in malaria-endemic countries …